Clarus Therapeutics Inc. has won FDA approval for the first oral formulation of testosterone with the approval of Jatenzo (testosterone udecanoate), a testosterone replacement therapy for certain adult men with conditions associated with a deficiency or absence of endogenous testosterone.
The March 27 approval represents a big milestone for Clarus, coming after a long development road and marking the first...